XTX Topco’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.4K | Buy |
+76,413
| New | +$41.4K | ﹤0.01% | 2054 |
|
|
2025
Q1 | – | Sell |
-21,817
| Closed | -$22.3K | – | 3015 |
|
|
2024
Q4 | $22.3K | Sell |
21,817
-81,899
| -79% | -$83.5K | ﹤0.01% | 2014 |
|
|
2024
Q3 | $89.8K | Buy |
103,716
+64,981
| +168% | +$56.3K | 0.01% | 1617 |
|
|
2024
Q2 | $13.9K | Buy |
38,735
+12,711
| +49% | +$4.55K | ﹤0.01% | 1658 |
|
|
2024
Q1 | $17.4K | Buy |
+26,024
| New | +$17.4K | ﹤0.01% | 1626 |
|
|
2023
Q4 | – | Sell |
-46,486
| Closed | -$27.9K | – | 2079 |
|
|
2023
Q3 | $27.9K | Sell |
46,486
-211,172
| -82% | -$127K | ﹤0.01% | 1344 |
|
|
2023
Q2 | $335K | Buy |
257,658
+51,324
| +25% | +$66.7K | 0.06% | 637 |
|
|
2023
Q1 | $363K | Buy |
206,334
+160,600
| +351% | +$283K | 0.08% | 504 |
|
|
2022
Q4 | $144K | Buy |
45,734
+8,617
| +23% | +$27.1K | 0.03% | 933 |
|
|
2022
Q3 | $182K | Buy |
+37,117
| New | +$182K | 0.05% | 815 |
|